Structure-guided engineering study demonstrates high N-oxidation selectivity in N-heterocycles using engineered P450BM3, highlighting a biocatalytic route for drug synthesis.
N-oxidation of N-heterocycles is essential in the synthesis of natural products but challenging due to low efficacy and poor regioselectivity. In this study, the N-oxidation selective potential of P450BM3 from Bacillus megaterium for N-heterocyclic compounds is investigated. Here, twelve amino acids located in the active center, including A74, L75, V78, A82, F87, I263, A264, A328, P329, A330, I401, and L437, are investigated by site-saturation mutation. As a result, F87, A264, L75, V78, A328, I401, and L437 are identified as hotspot residues. Subsequently, the combinatorial active-site saturation test/iterative saturation mutagenesis strategy is performed. Using quinoline as a model substrate, the mutant F87G/A264G/A328L exhibits N-oxidation selectivity of up to 99.0%, with a conversion rate of 99.3%. Molecular dynamics simulations uncover a “push-pull” molecular mechanism elucidating the pivotal role of steric factors in determining substrate recognition and N-oxidation selectivity. This study provides an efficient N-oxide synthesis method and insights into P450BM3’s molecular mechanisms. N-oxidation of N-heterocycles is essential in the synthesis of natural products and intermediates for pharmaceuticals and pesticides but challenging due to low efficacy and poor regioselectivity. Here, the authors employ structure-guided directed evolution of Bacillus megaterium P450BM3 to obtain variants with expanded N-oxidation selectivity for the synthesis of N-heterocyclic N-oxides.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: